Trial Profile
Prevention of Symptomatic Venous Thromboembolism by Low Molecular Weight Heparin in Hospitalized Medical Patients Aged 75 Years and Older : a Randomized Placebo-Controlled Study The SYMPTOMS (SYstematic Elderly Medical Patients Thromboprophylaxis : Efficacy on Symptomatic OutcoMeS) Study
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Jul 2022
Price :
$35
*
At a glance
- Drugs Enoxaparin sodium (Primary)
- Indications Thromboembolism
- Focus Therapeutic Use
- Acronyms SYMPTOMS
- 30 Jun 2022 Status changed from recruiting to completed.
- 06 Jun 2021 This trial has been discontinued in France, as per European Clinical Trials Database record.
- 28 Sep 2018 Planned End Date changed from 1 Dec 2018 to 1 Dec 2022.